Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Prof. Dr. Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

SVKM NMIMS Global University | India

Dr. Yogeeta Agrawal Goyal is a Professor of Pharmaceutics at SVKM NMIMS Global University, Dhule, with more than 19 years of teaching and research experience. She holds a Ph.D. from Jaipur National University with research at AIIMS New Delhi, an M.Pharm with distinction and gold medal from The M.S. University of Baroda, a B.Pharm with multiple university gold medals from Nagpur University, and a PG Diploma in Patent Law from NALSAR University. Her research expertise lies in lipid-based nanoparticles, transdermal and controlled drug delivery, nose-to-brain targeting, and nanomedicine for brain and tumour therapies. She has published over 50 international and 3 national papers in reputed SCI-indexed journals with an impact factor above 183, authored two books, contributed several book chapters, and holds patents. She has guided numerous postgraduate and doctoral students, completed government and institutional funded projects from DBT, AYUSH, and SVKM, and presented at national and international forums. Her achievements include multiple gold medals, the G.P. Nair Award from IDMA, outstanding performance awards, and recognition through fellowships and grants. She is actively involved in academic associations such as IPA, APTI, and MSU Alumni, while also serving on editorial boards and advisory roles, making impactful contributions to pharmaceutical sciences through teaching, research, innovation, and community development.

Profiles: Scopus | Google Scholar | Orcid

Featured Publication

Goyal, S. N., Reddy, N. M., Patil, K. R., Nakhate, K. T., Ojha, S., Patil, C. R., … Agrawal, Y. O. (2016). Challenges and issues with streptozotocin-induced diabetes–A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biological Interactions, 244, 49–63.

Agrawal, Y., Petkar, K. C., & Sawant, K. K. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International Journal of Pharmaceutics, 401(1–2), 93–102.

Agrawal, Y. O., Sharma, P. K., Shrivastava, B., Ojha, S., Upadhya, H. M., Arya, D. S., … Goyal, S. N. (2014). Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats. PLOS ONE, 9(11), e111212.

Goyal, S. N., Sharma, C., Mahajan, U. B., Patil, C. R., Agrawal, Y. O., Kumari, S., … Ojha, S. (2015). Protective effects of cardamom in isoproterenol-induced myocardial infarction in rats. International Journal of Molecular Sciences, 16(11), 27457–27469.

Eddin, L. B., Jha, N. K., Goyal, S. N., Agrawal, Y. O., Subramanya, S. B., Bastaki, S. M. A., … Ojha, S. (2022). Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of α-bisabolol. Nutrients, 14(7), 1370.

Sandeep Zokande | Pharmaceutical analysis | Best Researcher Award

Published-on by Indian Scientist

Dr. Sandeep Zokande | Pharmaceutical analysis | Best Researcher Award

Indoco Remedies Limited, India

Author Profile

SCOPUS

🎓 EARLY ACADEMIC PURSUITS

Dr. Sandeep Shidu Zokande began his academic journey with a B.Sc. in Chemistry from Shivaji University in 1991. His deep interest in analytical sciences led him to pursue M.Sc. in Analytical Chemistry from Mumbai University in 1995, culminating in a Ph.D. in Analytical Chemistry from the same prestigious institution in 2001. His early years laid a strong foundation in instrumentation, spectroscopy, and chromatography, which would define his prolific career in pharmaceutical analysis.

🏢 PROFESSIONAL ENDEAVORS

With over 24 years of impactful industry experience, Dr. Zokande has held senior leadership roles across Indoco Analytical Solutions, Indoco Remedies Ltd., Sandoz Pvt. Ltd., S. Zhaveri Pharmachem, Rubicon Research, and WRIC, Mumbai University.

  • Vice President, Indoco Analytical Solutions (Since July 2024): Leads a team of 16 scientists, managing analytical portfolios for oral solids, injectables, ophthalmics, suspensions, and solutions.

  • Vice President, Indoco Remedies Ltd. (2011–2024): Headed a department of 115 scientists, responsible for analytical strategies for over 100 ANDAs and numerous global dossiers.

  • Head, S. Zhaveri Pharmachem (Two terms): Directed method development, validation, and customer communication.

  • Senior Group Analytical Expert, Sandoz (2004–2010): Led a 40-member team for regulatory compliance and method validation.

  • Product Development Officer, Rubicon Research and Project Assistant, WRIC, University of Mumbai: Early roles involved critical method development and national-level training organization.

📚 CONTRIBUTIONS AND RESEARCH FOCUS IN PHARMACEUTICAL ANALYSIS

Dr. Zokande has consistently advanced the field of pharmaceutical analysis, with expertise in:

  • Analytical method development and validation

  • Stability studies, impurity profiling

  • Regulatory submissions (ANDA, EU, ANVISA, TGA)

  • DMF revisions and scientific write-ups

  • Global regulatory compliance & SOP development

  • Laboratory setup and audit readiness

His analytical leadership has played a crucial role in First-To-File (FTF) strategies and reducing regulatory risk through stringent quality control and scientific documentation.

🏅 ACADEMIC CITATIONS, ACCOLADES AND RECOGNITION

  • Reviewer for:

    • Journal of Pharmaceutical Sciences

    • European Journal of Hospital Pharmacy

  • USP Monograph Donor Recognition Award (2024)

  • Sandoz “Function of the Year” Awards (2005, 2010)

  • Special MD Award for exemplary leadership during the COVID-19 pandemic

  • Honored by national and international clients for scientific excellence

  • IQAC and Board of Studies member, BNCP College of Pharmacy

  • Guest lecturer, sharing his vast industry insights with future pharma professionals

🌍 IMPACT AND INFLUENCE

  • Leader of teams exceeding 100+ scientists, promoting scientific integrity, efficiency, and talent development.

  • Actively participated in USFDA, EU, ANVISA, and TGA audits, ensuring zero major observations.

  • Mentored the setup of world-class laboratories, including Indoco Remedies, Sandoz Development Centre, and Ratnagiri University sub-centre.

  • Invited panelist at the Express Pharma Analytical Conclave (2022).

  • Business representation in Slovakia, Latvia, and Singapore, promoting Indian pharmaceutical excellence abroad.

🧭 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zokande’s legacy is one of scientific rigor, visionary leadership, and commitment to global pharmaceutical standards. His future contributions are focused on:

  • Mentorship of next-generation analytical scientists

  • Driving regulatory harmonization and scientific documentation standards

  • Developing green analytical methods and AI-supported analytics

  • Establishing training centers for real-world pharmaceutical skill building

 ✅CONCLUSION

Dr. Sandeep Shidu Zokande is a pioneering force in pharmaceutical analysis, recognized for his strategic leadership, regulatory expertise, and global impact. From laboratory benches to boardrooms, his career reflects a relentless pursuit of excellence, setting benchmarks in analytical science and regulatory compliance. His legacy will continue to shape India’s pharmaceutical innovation and integrity on the world stage.

🔬NOTABLE PUBLICATION:

Degradation products of nepafenac ophthalmic suspension and accurate structural characterization of 8-benzoyl-1,2-dihydrocinnolin-3(4H)-one through forced degradation and spectral studies

Journal: Results in Chemistry

Year: 2025